Related references
Note: Only part of the references are listed.Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression
Shengchen Lin et al.
CANCER LETTERS (2021)
Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
Yinan Xiao et al.
ONCOGENE (2021)
Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma
Kenichi Matsumoto et al.
CANCER LETTERS (2021)
Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
Krzysztof Kotowski et al.
CANCERS (2021)
Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
Tiago De Oliveira et al.
CANCERS (2021)
Inhibition of Glycolysis Suppresses Cell Proliferation and Tumor Progression In Vivo: Perspectives for Chronotherapy
Jana Horvathova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3
Andrew J. Robinson et al.
CANCER RESEARCH (2020)
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
Jia Liu et al.
NATURE COMMUNICATIONS (2020)
c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3
Huanhuan Ma et al.
CELL REPORTS (2020)
O-GlcNAcylation of PFKFB3 is required for tumor cell proliferation under hypoxia
Yinrui Lei et al.
ONCOGENESIS (2020)
Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)
Besa Emini Veseli et al.
FEBS LETTERS (2020)
p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis
Fang Wang et al.
CANCER RESEARCH (2020)
PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationships
Yinhu Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
Susmita Mondal et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3
Xinling Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?
Zahra Ghanbari Movahed et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival
Nadiia Lypova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice
Olga Burmistrova et al.
SCIENTIFIC REPORTS (2019)
The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis
Bahar Yetkin-Arik et al.
SCIENTIFIC REPORTS (2019)
Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties
Nicolas Boutard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation
Xueqiang Deng et al.
EXPERIMENTAL CELL RESEARCH (2019)
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer
Mei Yi et al.
MOLECULAR METABOLISM (2019)
Tuning PFKFB3 Bisphosphatase Activity Through Allosteric Interference
Helena Macut et al.
SCIENTIFIC REPORTS (2019)
A High-Throughput Screening Triage Workflow to Authenticate a Novel Series of PFKFB3 Inhibitors
Stephen A. St-Gallay et al.
SLAS DISCOVERY (2018)
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou et al.
BMC CANCER (2018)
Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer
Zhen Xing et al.
CANCER RESEARCH (2018)
Hidden features: exploring the non-canonical functions of metabolic enzymes
Peiwei Huangyang et al.
DISEASE MODELS & MECHANISMS (2018)
The potential utility of PFKFB3 as a therapeutic target
Ramon Bartrons et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy
Xiaoli Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor
Yu Zhu et al.
ONCOGENE (2018)
Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4
Wenzhi Jia et al.
ONCOGENE (2018)
PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT
Wen-Kai Shi et al.
CELL DEATH & DISEASE (2018)
Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis
Fu-Long Li et al.
NATURE COMMUNICATIONS (2018)
Four Key Steps Control Glycolytic Flux in Mammalian Cells
Lukas Bahati Tanner et al.
CELL SYSTEMS (2018)
Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
Subhamoy Dasgupta et al.
NATURE (2018)
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Nina M. S. Gustafsson et al.
NATURE COMMUNICATIONS (2018)
Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
Hui-Min Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells
Charlotte Taylor et al.
ONCOTARGET (2017)
Roles of PFKFB3 in cancer
Linlin Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism
Xin Zheng et al.
EMBO JOURNAL (2017)
Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes
Amina Houddane et al.
CELLULAR SIGNALLING (2017)
mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival
Yonghuai Feng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
Anna Rita Cantelmo et al.
CANCER CELL (2016)
PFK-158 is a first-in-human inhibitor of PFKFB3 that selectively suppresses glucose metabolism of cancer cells and inhibits the immunosuppressive Th17 cells and MDSCs in advanced cancer patients
Sucheta Telang et al.
CANCER RESEARCH (2016)
IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3
Michael A. Reid et al.
GENES & DEVELOPMENT (2016)
Glycolytic regulation of cell rearrangement in angiogenesis
Bert Cruys et al.
NATURE COMMUNICATIONS (2016)
PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs
Lili Chen et al.
SCIENTIFIC REPORTS (2016)
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
Laura Pisarsky et al.
CELL REPORTS (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
Wei Zhu et al.
PLOS ONE (2016)
PFK-158, first-in-man and first-in-class inhibitor of PFKFB3/glycolysis: A phase I, dose escalation, multi-center study in patients with advanced solid malignancies
Rebecca Redman et al.
CANCER RESEARCH (2015)
Bioenergetic Mechanisms in Astrocytes May Contribute to Amyloid Plaque Deposition and Toxicity
Wen Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3
Scott Boyd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest
Elena Domenech et al.
NATURE CELL BIOLOGY (2015)
The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells
Artur Cieslar-Pobuda et al.
ONCOTARGET (2015)
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models
Chrysi Xintaropoulou et al.
ONCOTARGET (2015)
Endothelial PFKFB3 Plays a Critical Role in Angiogenesis
Yiming Xu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation
Enrico Desideri et al.
AUTOPHAGY (2014)
Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)
Darby G. Brooke et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
Sandra Schoors et al.
CELL METABOLISM (2014)
Phosphofructokinase: A mediator of glycolytic flux in cancer progression
Nada Al Hasawi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Cancer Stem Cell Theory and the Warburg Effect, Two Sides of the Same Coin?
Nicola Pacini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Estradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase ( PFKFB3)
Yoannis Imbert-Fernandez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer
Minsuh Seo et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Oleksandr H. Minchenko et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
A. Yalcin et al.
CELL DEATH & DISEASE (2014)
Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
Takehiro Yamamoto et al.
NATURE COMMUNICATIONS (2014)
Fructose-2,6-Bisphosphate synthesis by 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth
Jason Chesney et al.
ONCOTARGET (2014)
PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli
Laura Novellasdemunt et al.
BIOCHEMICAL JOURNAL (2013)
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Katrien De Bock et al.
CELL (2013)
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells
Zhen Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Targeting 6-Phosphofructo-2-Kinase ( PFKFB3) as a Therapeutic Strategy against Cancer
Brian F. Clem et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells
Laura Novellasdemunt et al.
BIOCHEMICAL JOURNAL (2012)
Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration
P. Rodriguez-Rodriguez et al.
CELL DEATH AND DIFFERENTIATION (2012)
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival
V. Goidts et al.
ONCOGENE (2012)
Reversible High Affinity Inhibition of Phosphofructokinase-1 by Acyl-CoA A MECHANISM INTEGRATING GLYCOLYTIC FLUX WITH LIPID METABOLISM
Christopher M. Jenkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect
Minsuh Seo et al.
PLOS ONE (2011)
Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-β-TrCP, sequentially regulate glycolysis during the cell cycle
Slavica Tudzarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Evolution of Allosteric Citrate Binding Sites on 6-phosphofructo-1-kinase
Aleksandra Usenik et al.
PLOS ONE (2010)
Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases
Abdullah Yalcin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1
Angel Herrero-Mendez et al.
NATURE CELL BIOLOGY (2009)
ATP and fructose-2,6-bisphosphate regulate skeletal muscle 6-phosphofructo-1-kinase by altering its quaternary structure
Patricia Zancan et al.
IUBMB LIFE (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas
Renate Kessler et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Fructose-2,6-bisphosphate counteracts guanidinium chloride-, thermal-, and ATIP-induced dissociation of skeletal muscle key glycolytic enzyme 6-phosphofructo-1-kinase: A structural mechanism for PFK allosteric regulation
Patricia Zancan et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis
Tiago Costa Leite et al.
BIOCHEMICAL JOURNAL (2007)
A direct substrate-substrate interaction found in the kinase domain of the bifunctional enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
Song-Gun Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Hypoxia, glucose metabolism and the Warburg's effect
Ramon Bartrons et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Crystal structure of the hypoxia-inducible form of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) - A possible new target for cancer therapy
SG Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation
T Atsumi et al.
DIABETES (2005)
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors
OH Minchenko et al.
BIOCHIMIE (2005)
Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer
H Bando et al.
CLINICAL CANCER RESEARCH (2005)
The kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate
NP Manes et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene
M Fukasawa et al.
JOURNAL OF BIOCHEMISTRY (2004)
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: Head-to-head with a bifunctional enzyme that controls glycolysis
MH Rider et al.
BIOCHEMICAL JOURNAL (2004)
6-phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia
M Obach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo
O Minchenko et al.
FEBS LETTERS (2003)
The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase
AS Marsin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene -: Its possible role in the Warburg effect
A Minchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: suiting structure to need, in a family of tissue-specific enzymes
MR El-Maghrabi et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2001)
The human ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3):: promoter characterization and genomic structure
A Navarro-Sabaté et al.
GENE (2001)
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate
DO Okar et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Share Paper
